MAIA Biotechnology Files 8-K
Ticker: MAIA · Form: 8-K · Filed: Jun 24, 2025 · CIK: 1878313
| Field | Detail |
|---|---|
| Company | Maia Biotechnology, INC. (MAIA) |
| Form Type | 8-K |
| Filed Date | Jun 24, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: regulatory-filing, 8-k
TL;DR
MAIA Bio filed an 8-K, but it's light on details for now.
AI Summary
MAIA Biotechnology, Inc. filed an 8-K on June 24, 2025, reporting other events and financial statements. The filing does not contain specific details about the nature of these events or any financial figures.
Why It Matters
This filing indicates that MAIA Biotechnology, Inc. has made a regulatory submission, but the lack of specific details prevents an immediate assessment of its impact.
Risk Assessment
Risk Level: low — The filing is a standard 8-K for 'Other Events' and 'Financial Statements and Exhibits' without disclosing specific material events, making it low risk.
Key Players & Entities
- MAIA Biotechnology, Inc. (company) — Registrant
- June 24, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- 001-41455 (commission_file_number) — SEC File Number
- 444 West Lake Street, Suite 1700 (address) — Principal executive offices
- Chicago, IL (location) — City and State of principal executive offices
- 60606 (zip_code) — Zip code of principal executive offices
- (312) 416-8592 (phone_number) — Registrant's telephone number
FAQ
What specific 'Other Events' are being reported by MAIA Biotechnology, Inc. in this 8-K?
The filing does not specify the nature of the 'Other Events' beyond listing it as an item information category.
What is the purpose of filing 'Financial Statements and Exhibits' as an item in this 8-K?
The filing lists 'Financial Statements and Exhibits' as an item, but does not provide the actual financial statements or detail which exhibits are included.
When was the earliest event reported in this 8-K filing?
The earliest event reported is dated June 24, 2025.
Where is MAIA Biotechnology, Inc. headquartered?
MAIA Biotechnology, Inc.'s principal executive offices are located at 444 West Lake Street, Suite 1700, Chicago, IL 60606.
What is the SEC file number for MAIA Biotechnology, Inc.?
The SEC file number for MAIA Biotechnology, Inc. is 001-41455.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 24, 2025 regarding MAIA Biotechnology, Inc. (MAIA).